Last update 05 Mar 2026

Macera therapeutics

Private Company|2022|Jiangsu Sheng, China

Overview

Tags

Digestive System Disorders
Neoplasms
Macrophage therapy
CAR-M
Cell therapy

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Neoplasms2
Top 5 Drug TypeCount
Macrophage therapy1
CAR-M1
Cell therapy1
Top 5 TargetCount
HER2(Receptor tyrosine-protein kinase erbB-2)1

Related

3
Drugs associated with Macera therapeutics
Human HER2-targeted CAR-M cells(Macera therapeutics)
Target
HER2
Mechanism
HER2 antagonists
Active Org.
Macera therapeutics
Originator Org.
Macera therapeutics
Active Indication
HER2-positive gastric cancer
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
MACF-001
Target-
Mechanism-
Active Org.
Macera therapeutics
Originator Org.
Macera therapeutics
Active Indication
Compensated cirrhosis
Inactive Indication-
Drug Highest PhaseClinical
First Approval Ctry. / Loc.-
First Approval Date-
WO2024093147
Patent Mining
Target-
Mechanism-
Active Org.
Macera therapeutics
Originator Org.
Macera therapeutics
Active Indication
Neoplasms
Inactive Indication-
Drug Highest PhaseDiscovery
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Macera therapeutics
NCT06224738
/ Unknown statusEarly Phase 1IIT
Human HER2-targeted Chimeric Antigen Receptor Macrophages Therapy for HER2-positive Advanced Gastric Cancer With Peritoneal Metastases: an Exploratory Clinical Trial
100 Clinical Results associated with Macera therapeutics
Login to view more data
0 Patents (Medical) associated with Macera therapeutics
Login to view more data
100 Deals associated with Macera therapeutics
Login to view more data
100 Translational Medicine associated with Macera therapeutics
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 01 Apr 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
1
1
Phase 1
Other
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Human HER2-targeted CAR-M cells(Macera therapeutics)
 ( HER2 )		HER2-positive gastric cancer
More
Phase 1
MACF-001
Compensated cirrhosis
More
Clinical
WO2024093147
Patent Mining		Neoplasms
More
Discovery
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free